Why remdesivir, a highly effective treatment, is a last resort for providers
The antiviral infusion was just revived as an early treatment for COVID patients. But the drug is relatively expensive and hard to administer, relegating it what some are calling "stopgap" status. http://dlvr.it/SJZhzH
No comments:
Post a Comment